PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Center for Advancing Translational Sciences, 9800 Medical Center Drive, Rockville, Maryland 20850, United States.\', \'Southern Research Institute, 2000 Ninth Avenue South, Birmingham, Alabama 35205, United States.\', \'Optical Sciences Division, Code 5600, Naval Research Laboratory, Washington, D.C. 20375, United States.\', \'Jacobs Corporation, Hanover, Maryland 21076, United States.\', \'Department of Immunology and Microbiology, IMM6, The Scripps Research Institute, La Jolla, California 92037, United States.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acsinfecdis.0c00349
?:hasPublicationType
?:journal
  • ACS infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33346633
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.618
?:rankingScore_hIndex
  • 13
is ?:relation_isRelatedTo_publication of
?:title
  • The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all